RCEL EBITDA Growth
Avita Medical Inc · EBITDA Growth
RCEL EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported21.20%period ending
RCEL TTM EBITDA YoY % (-5.74% → 21.20%)
Year-over-year change
High-resolution chart · PNG
RCEL ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 21.2049% | |
| 25.0571% | |
| 25.419% | |
| 19.1146% | |
| 1.1362% | |
| -21.1151% | |
| -64.8927% | |
| -55.1608% | |
| -50.9899% | |
| -61.0775% | |
| -28.7771% | |
| -13.4886% | |
| -1.7521% | |
| 7.188% | |
| -7.0968% | |
| -34.7743% | |
| -13.8683% | |
| 18.6785% | |
| 54.2336% | |
| 65.4534% | |
| 57.2594% | |
| 40.7435% | |
| -23.5116% | |
| -76.5101% | |
| -71.4544% | |
| -85.4593% | |
| -63.5658% | |
| -54.7889% | |
| -88.8403% | |
| -87.9388% | |
| -72.6349% | |
| -64.5639% | |
| -48.1678% | |
| -42.3342% | |
| -42.4836% | |
| -26.3735% | |
| -11.5166% | |
| -8.1747% | |
| -5.0148% | |
| -17.4969% | |
| -31.0917% | |
| -37.888% | |
| -46.1333% | |
| -39.3331% | |
| -31.8399% | |
| -9.4795% | |
| 10.027% | |
| 18.2491% | |
| 22.4399% | |
| 9.8543% | |
| -5.7403% |